Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 (Listing Regulations), Vivimed Labs has informed that it enclosed Related Party Transactions on a consolidated basis for the half year ended 31.03.2022. The financial results have been approved by the Board of Directors on 03.06.2022.
The above information is a part of company’s filings submitted to BSE.